Methylome Variation Predicts Exemestane Resistance in Advanced ER+ Breast Cancer.

Xiao-Ran LiuRu-Yan ZhangHao GongHope S RugoLing-Bo ChenYuan FuJian-Wei CheJian TieBin ShaoFeng-Ling WanWei-Yao KongGuo-Hong SongHan-Fang JiangGuo-Bing XuHui-Ping Li

Published in: Technology in cancer research & treatment (2020)

Methylation change in chromosome 6 [149600000-149799999] is an ideal predictor of exemestane resistance with great clinical potential.

Keyphrases

metastatic breast cancer
dna methylation
genome wide
gene expression
human health
young adults